Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220.
GOLD. global initiative for chronic obstructive lung disease. Updated 2008. http://www.goldcopd.com.
Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–84.
Serra-Batlles J, Plaza V, Badiola C, Morejón E. Inhalation Devices Study Group. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med. 2002;15(1):59–64.
Hesselink AE, Penninx BW, Wijnhoven HA, Kriegsman DM, van Eijk JT. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scand J Prim Health Care. 2001;19(54):255–60.
World Health Organization. Adherence to long-term therapies. Evidence for action. Geneva: WHO; 2003.
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.
Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837–41.
Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 1999;93(2):88–94.
Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest. 1998;113(3):587–92.
Mapel DW, Picchi MA, Hurley JS, Frost FJ, Petersen HV, Mapel VM, et al. Utilization in COPD: patient characteristics and diagnostic evaluation. Chest. 117(5 Suppl 2):346S-53S.
van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57(5):412–6.
Dalon F, Van Ganse E. Correia Da Silva C, Nachbaur G, Saïl L, Belhassen M. Therapeutic adherence in chronic obstructive pulmonary disease: a literature review Rev Mal Respir. 2019. https://doi.org/10.1016/j.rmr.2019.06.005.
Bryant J, McDonald VM, Boyes A, Sanson-Fisher R, Paul C, Melville J. Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2013;14:109.
Scherer YK, Schmieder LE, Shimmel S. The effects of education alone and in combination with pulmonary rehabilitation on self-efficacy in patients with COPD. Rehabil Nurs. 1996;23(2):71–7.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med care. 1986;24(1):67–74.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–70.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.
Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–7.
Spencer S, Calverley PM, Sherwood Burge P, Jones PW, ISOLDE Study Group. Inhaled steroids in obstructive lung disease. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:122–8.
Jones PW, Quirk FH, Baveystock CM. The St. George’s Respiratory Questionnaire. Respir Med. 1991;85(Suppl. B):25–31.
Field A. Discovering statistics using SPSS. 2nd ed. London: Sage; 2000.
NICE Guideline - COPD in over 16s: diagnosis and management" (2018). https://www.nice.org.uk/guidance/ng115.
Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley- Interscience Publication; 2000.
Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J. 2000;16(6):1037–42.
George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128(5):3198–204.
Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient's perspective. J Gen Int Med. 2002;17(10):749–55.
Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: analyzing factors associated with a successful treatment. Pulmonology. 2019. https://doi.org/10.1016/j.pulmoe.2019.05.012.
Humenberger M, Horner A, Labek A, Kaiser B, Frechinger R, Brock C, Lichtenberger P, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163.
Wiśniewski D, Porzezińska M, Gruchała-Niedoszytko M, Niedoszytko M, Słomiński JM, Jassem E. Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol. 2014;82(2):96–104.
Mohsen S, Hanafy FZ, Fathy AA, El-Gilany AH. Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease. Lung India. 2019;36(3):193–8.
Barja-Martínez E, Casas-González S, Simón-López AF, Mancheño-Ovejero C, Padial-de la Cruz MLG. Adherence to inhaled therapy in the outpatient setting. Enferm Clin. 2019;29(1):34–8.
Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: understanding patients' adhereunce to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767–73.
Jarab AS, Alqudah S. Khdour M, Shamssain M, Mukattash T. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53–62.
Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012;68(10):1365–73.
Ágh T, Inotai A, Mészáros Á. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. 2011;82(4):328–34.
Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007;32(6):603–11.
Krigsman K, Nilsson JL, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16(10):1120–8.
American Lung Association (ALA). American lung association fact sheet: chronic obstructive pulmonary disease; 2006. Available from https://www.Lungusa.org/diseases/copd_factsheet.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.
Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano A Jr, et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? meta-analysis of published reports. BMJ. 2002;325(7370):925.
Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depuressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246–52.
DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(4):521–8.
Kampman O, Laippala P, Väänänen J, Koivisto E, Kiviniemi P, Kilkku N, et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002;110(1):39–48.
Nasser EH, Overholser JC. Recovery from major depression: the role of support from family, friends, and spiritual beliefs. Acta Psychiatr Scand. 2005;111(2):125–32.
Toy EL, Beaulieu NU, McHale JM, Welland TR, Plauschinat CA, Swensen A, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Resp Med. 2011;105(3):435–41.
Prajapati R, Shrestha S. Medication adherence and its associated factors among COPD patients attending medical OPD of Dhulikhel hospital. Nepal IJNRP. 2015;2(1):15–9.